Clinicopathological and prognostic value of epithelial cell adhesion molecule in solid tumours: a meta-analysis

Clinicopathological and prognostic value of epithelial cell adhesion molecule in solid tumours: a meta-analysis

BackgroundMalignant tumors, mainly solid tumors, are a significant obstacle to the improvement of life expectancy at present. Epithelial cell adhesion molecule (EpCAM), a cancer stem cell biomarker, showed widespread expression in most normal epithelial cells and most cancers. Although the clinical...

Full description

Bibliographic Details
Main Authors:	Peiwen Ding, Panyu Chen, Jiqi Ouyang, Qiang Li, Shijie Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-08-01
Series:	Frontiers in Oncology
Subjects:	EpCAM solid tumors prognosis cancer stem cells biomarkers meta-analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1242231/full

Similar Items

Epithelial cell adhesion molecule (EpCAM) regulates HGFR signaling to promote colon cancer progression and metastasis
by: Chi-Chiu Lee, et al.
Published: (2023-08-01)

A meta-analysis and The Cancer Genome Atlas data of prostate cancer risk and prognosis using epithelial cell adhesion molecule (EpCAM) expression
by: Yu Hu, et al.
Published: (2019-07-01)

The association between Annexin A2 and epithelial cell adhesion molecule in breast cancer cells
by: Saad Misfer Al‐Qahtani, et al.
Published: (2022-05-01)

Immunohistochemical Expression of Epithelial Cell Adhesion Molecule (EpCAM) in Salivary Gland Cancer: Correlation with the Biological Behavior
by: Ioanna Kalaitsidou, et al.
Published: (2023-08-01)

An Intrabody against B-Cell Receptor-Associated Protein 31 (BAP31) Suppresses the Glycosylation of the Epithelial Cell-Adhesion Molecule (EpCAM) via Affecting the Formation of the Sec61-Translocon-Associated Protein (TRAP) Complex
by: Tianyi Wang, et al.
Published: (2023-09-01)

Absence of EpCAM in cervical cancer cells is involved in sluginduced epithelial‐mesenchymal transition
by: Xian Liu, et al.
Published: (2021-03-01)

Chimeric Antigen Receptor T Cell Therapy Targeting Epithelial Cell Adhesion Molecule in Gastric Cancer: Mechanisms of Tumor Resistance
by: Yanping Yang, et al.
Published: (2023-11-01)

EpCAM (CD326) Regulates Intestinal Epithelial Integrity and Stem Cells via Rho-Associated Kinase
by: Takeshi Ouchi, et al.
Published: (2021-01-01)

Congenital Tufting Enteropathy-Associated Mutant of Epithelial Cell Adhesion Molecule Activates the Unfolded Protein Response in a Murine Model of the Disease
by: Barun Das, et al.
Published: (2020-04-01)

Recent advances of bispecific antibodies in solid tumors
by: Shengnan Yu, et al.
Published: (2017-09-01)

Digital scoring of EpCAM and slug expression as prognostic markers in head and neck squamous cell carcinomas
by: Henrik Schinke, et al.
Published: (2021-04-01)

Destabilization of EpCAM dimer is associated with increased susceptibility towards cleavage by TACE
by: Tomaž Žagar, et al.
Published: (2021-05-01)

Influence of the Position and Composition of Radiometals and Radioiodine Labels on Imaging of Epcam Expression in Prostate Cancer Model Using the DARPin Ec1
by: Sergey M. Deyev, et al.
Published: (2021-07-01)

Diagnostic and Prognostic Values of Serum EpCAM, TGM2, and HE4 Levels in Endometrial Cancer
by: Ting Lan, et al.
Published: (2020-09-01)

EpCAM Immunotherapy versus Specific Targeted Delivery of Drugs
by: Joanna Macdonald, et al.
Published: (2018-01-01)

Anti-Epcam Aptamer (Syl3c)-Functionalized Liposome for Targeted Delivery Of Doxorubicin: In Vitro And In Vivo Antitumor Studies in Mice Bearing C26 Colon Carcinoma
by: Mohammad Mashreghi, et al.
Published: (2020-05-01)

Optical Aptamer Probes of Fluorescent Imaging to Rapid Monitoring of Circulating Tumor Cell
by: Ji Yeon Hwang, et al.
Published: (2016-11-01)

CRISPR/Cas9 disruption of EpCAM Exon 2 results in cell-surface expression of a truncated protein targeted by an EpCAM specific T cell engager
by: Andisheh Bagheri, et al.
Published: (2022-03-01)

Simulation and Stability Assessment of Anti-EpCAM Immunotoxin for Cancer Therapy
by: Seyed-Ali Hosseinian, et al.
Published: (2018-08-01)

Circulating tumor cells detected with a microcavity array predict clinical outcome in hepatocellular carcinoma
by: Kazuto Takahashi, et al.
Published: (2021-04-01)

Comparison of circulating tumor cell (CTC) detection rates with epithelial cell adhesion molecule (EpCAM) and cell surface vimentin (CSV) antibodies in different solid tumors: a retrospective study
by: Yang Gao, et al.
Published: (2021-03-01)

Circulating Tumor Cells Adhesion: Application in Biosensors
by: Eduarda B. Paglia, et al.
Published: (2023-09-01)

Fraction of MHCII and EpCAM expression characterizes distal lung epithelial cells for alveolar type 2 cell isolation
by: Koichi Hasegawa, et al.
Published: (2017-08-01)

Oncolytic vaccinia virus expressing a bispecific T-cell engager enhances immune responses in EpCAM positive solid tumors
by: Min Wei, et al.
Published: (2022-11-01)

Development of a Novel Anti-EpCAM Monoclonal Antibody for Various Applications
by: Guanjie Li, et al.
Published: (2022-06-01)

Loss of TROP2 and epithelial cell adhesion molecule expression is linked to grade progression in pTa but unrelated to disease outcome in pT2-4 urothelial bladder carcinomas
by: Jan H. Müller, et al.
Published: (2024-01-01)

Dynamic Expression of EpCAM in Primary and Metastatic Lung Cancer Is Controlled by Both Genetic and Epigenetic Mechanisms
by: Yeting Cui, et al.
Published: (2022-08-01)

Gene delivery to breast cancer by incorporated EpCAM targeted DARPins into AAV2
by: Ya-feng Lv, et al.
Published: (2023-12-01)

A Polyamidoamine Dendrimer-Based Electrochemical Immunosensor for Label-Free Determination of Epithelial Cell Adhesion Molecule- Expressing Cancer Cells
by: Jianguo Xu, et al.
Published: (2019-04-01)

Complex Alterations of Fatty Acid Metabolism and Phospholipidome Uncovered in Isolated Colon Cancer Epithelial Cells
by: Jiřina Hofmanová, et al.
Published: (2021-06-01)

Understanding the versatile roles and applications of EpCAM in cancers: from bench to bedside
by: Yiyang Liu, et al.
Published: (2022-11-01)

Beta-Hydroxyisovaleryl-Shikonin Eradicates Epithelial Cell Adhesion Molecule-Positive Liver Cancer Stem Cells by Suppressing dUTP Pyrophosphatase Expression
by: Yoshiro Asahina, et al.
Published: (2023-11-01)

mRNA-Lipid Nanoparticle (LNP) Delivery of Humanized EpCAM-CD3 Bispecific Antibody Significantly Blocks Colorectal Cancer Tumor Growth
by: Vita Golubovskaya, et al.
Published: (2023-05-01)

Characteristics of Extracellular Vesicles from a High-Grade Serous Ovarian Cancer Cell Line Derived from a Platinum-Resistant Patient as a Potential Tool for Aiding the Prediction of Responses to Chemotherapy
by: Katarina Černe, et al.
Published: (2023-06-01)

Dual Targeting of Cancer Cells with DARPin-Based Toxins for Overcoming Tumor Escape
by: Elena Shramova, et al.
Published: (2020-10-01)

Radionuclide Molecular Imaging of EpCAM Expression in Triple-Negative Breast Cancer Using the Scaffold Protein DARPin Ec1
by: Anzhelika Vorobyeva, et al.
Published: (2020-10-01)

Feasibility of Imaging EpCAM Expression in Ovarian Cancer Using Radiolabeled DARPin Ec1
by: Anzhelika Vorobyeva, et al.
Published: (2020-05-01)

EpCAM as a novel therapeutic target for hepatocellular carcinoma
by: Vasanthakumar S, et al.
Published: (2017-07-01)

Immunohistochemical Expression and Clinical Significance of Suggested Stem Cell Markers in Hepatocellular Carcinoma
by: Jong Jin Sung, et al.
Published: (2016-01-01)

Circulating tumor cells: the substrate of personalized medicine?
by: Bryan eGreene, et al.
Published: (2012-07-01)